T. Rowe Price Investment Management
PFE icon

T. Rowe Price Investment Management’s Pfizer PFE Stock Holding History

T. Rowe Price Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
56,140
+20,293
+57% +$531K ﹤0.01% 711
2026
Q1 		$1.01M Buy
+35,847
New +$954K ﹤0.01% 622
2025
Q3 		– Sell
-1,354
Closed -$33K – 920
2025
Q2 		$33K Buy
+1,354
New +$31.6K ﹤0.01% 668

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management's PFE Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Pfizer (PFE) stake by 57% in Q2 2026, buying an estimated $531K and bringing the position to 56,140 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #711.

T. Rowe Price Investment Management first reported a position in PFE in Q2 2025 and has held it in 3 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • T. Rowe Price Investment Management held 56,140 shares of Pfizer worth $1.35M as of Q2 2026.
  • T. Rowe Price Investment Management bought 20,293 Pfizer shares in Q2 2026, an estimated $531K.
  • Pfizer made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #711 holding.
  • T. Rowe Price Investment Management first reported a position in Pfizer in Q2 2025 and has held it in 3 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.